Division of Gastroenterology, Department of Internal Medicine, Okayama Kyoritsu Hospital, Okayama, Japan.
Digestion. 2012;85(4):256-60. doi: 10.1159/000336352. Epub 2012 Mar 30.
BACKGROUND/AIMS: The relationship between gastroesophageal junction adenocarcinoma (GEJA) and Helicobacter pylori infection is not well defined; thus, we retrospectively investigated this relationship.
We examined 852 cases (646 men) of gastric cancer. GEJA was defined as type II according to the classification system of Siewert and Stein. We compared the prevalence of H. pylori infection and corporal gastritis in GEJA patients with distal gastric cancer.
GEJA was observed in 80 (including 6 cases of Barrett's esophageal cancer) of the 852 cases of gastric cancer examined (9.4%). The rate of H. pylori infection was significantly lower in patients with GEJA than in patients with distal gastric cancer (73.8 vs. 94.1%, p < 0.05). The prevalence of corporal gastritis was also significantly lower in patients with GEJA than in patients with distal gastric cancer (80.7 vs. 94.6%, p < 0.05). Concurrent H. pylori infection and corporal gastritis were not observed in patients with Barrett's esophageal cancer.
Our study demonstrated that GEJA has 2 etiologic types; one of these types is associated with H. pylori infection and resembles distal gastric cancer, and the other one is not associated with H. pylori infection or Barrett's esophageal cancer.
背景/目的:胃食管交界处腺癌(GEJA)与幽门螺杆菌感染之间的关系尚未明确;因此,我们对此进行了回顾性研究。
我们检查了 852 例(646 例男性)胃癌病例。GEJA 根据 Siewert 和 Stein 的分类系统定义为 II 型。我们比较了 GEJA 患者和远端胃癌患者中幽门螺杆菌感染和体部胃炎的患病率。
在检查的 852 例胃癌病例中,观察到 80 例(包括 6 例 Barrett 食管癌)GEJA(9.4%)。GEJA 患者的幽门螺杆菌感染率明显低于远端胃癌患者(73.8% vs. 94.1%,p < 0.05)。GEJA 患者的体部胃炎患病率也明显低于远端胃癌患者(80.7% vs. 94.6%,p < 0.05)。Barrett 食管癌患者中未观察到同时存在幽门螺杆菌感染和体部胃炎。
我们的研究表明,GEJA 有两种病因类型;其中一种与幽门螺杆菌感染相关,类似于远端胃癌,另一种与幽门螺杆菌感染或 Barrett 食管癌无关。